Fairvalue-Calculator Fairvalue-Calculator
EN DE

Neosem Inc (253590) Fair Value & Analysis

Technology · KR · Market cap 558B KRW

Price11,490 KRW
Fair Value2,137 KRW
Upside-81.4%
Quality95/100
Evidence: High Range 1,603 KRW – 2,671 KRW

Fair value as of: Jun 24, 2026

Analysis

Neosem Inc (253590) currently trades at 11,490 KRW, while our model-based Fair Value estimate is 2,137 KRW — implying the stock looks roughly 81.4% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Neosem Inc. manufactures and sells semiconductor inspection equipment. It offers memory burn-in, SSD, DRAM module, and LED tests; surface particle detectors; and automation test systems. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Neosem Inc (253590) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,137 KRW versus a price of 11,490 KRW — about −81% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 253590?
Our 21-model fair value for Neosem Inc is 2,137 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 11,490 KRW.
What is the quality score of 253590?
Neosem Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.